Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid

Thorax

Volumn 68, Issue 11, 2013, Pages 1037-1042

  Theron, Grant ^a   Peter, Jonny ^a   Meldau, Richard ^a   Khalfey, Hoosain ^a   Gina, Phindile ^a   Matinyena, Brian ^a   Lenders, Laura ^a   Calligaro, Gregory ^a   Allwood, Brian ^a   Symons, Gregory ^a   Govender, Ureshnie ^a   Setshedi, Mashiko ^a   Dheda, Keertan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; CENTRIFUGATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNIC GROUP; EXPERIMENTAL THERAPY; FEMALE; FLUORESCENCE SMEAR MICROSCOPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID CULTURE; LUNG LAVAGE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MIXED INFECTION; MTB RIF ASSAY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SOUTH AFRICAN; SPUTUM SMEAR; TIME TO TREATMENT; TRANSBRONCHIAL BIOPSY; TUBERCULIN TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; LUNG FLUID; SOUTH AFRICA;

TUBERCULOSIS;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84885793144     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203485     Document Type: Article

References (35)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009.
2. Getahun H, Harrington M, O'Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007;369:2042-49. (Pubitemid 46908825)
3. Peter JG, Theron G, van Zyl-Smit R, et al. Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012;40:1211-20.
4. WHO. Global tuberculosis control 2011. Publication no. WHO/HTM/TB/2011.16. Geneva, Switzerland: World Health Organization, 2011.
5. Dheda K, Lampe FC, Johnson MA, et al. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004;190:1670.
6. Hepple P, Ford N, McNerney R. Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review. Int J Tuberc Lung Dis 2012;16:579.
7. WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF SYSTEM. Publication number WHO/HTM/TB/2011.4. Geneva, Switzerland: World Health Organization, 2011.
8. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15.
9. Steingart K, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013; (1):CD009593.
10. Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012;64:580-8.
11. Teo J, Jureen R, Chiang D, et al. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the amplified Mycobacterium tuberculosis Direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011;49:3659-62.
12. Armand S, Vanhuls P, Delcroix G, et al. Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011;49:1772-76.
13. Cruciani M, Scarparo C, Malena M. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004;42:2321-25. (Pubitemid 38637876)
14. Scarparo C, Ricordi P, Ruggiero G, et al. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J Clin Microbiol 2004;42:1109.
15. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010;48:229-37.
16. Xpert MTB/RIF [package insert]. Cepheid S, CA, 300-7810 Rev. A, April 2009.
17. Barnard M, Gey van Pittius NC, van Helden P, et al. Diagnostic performance of Genotype® MTBDRplus Version 2 line probe assay is equivalent to the Xpert® MTB/RIF assay. J Clin Microbiol 2012;50:2712-16.
18. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. Croat Med J 2003;44:639-50. (Pubitemid 37392154)
19. Dean AGSK, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. http://www.OpenEpi.com (updated Sep 2010; accessed 30 Nov 2010).
20. Miller MB, Popowitch EB, Backlund MG, et al. Performance of Xpert MTB/RIF RUO assay and IS6110 real-time PCR for Mycobacterium tuberculosis detection in clinical samples. J Clin Microbiol 2011;49:3458.
21. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 2011;49:4138-41.
22. Simonnet C, Lacoste V, Drogoul AS, et al. Automated extraction and amplification for direct detection of mycobacterium tuberculosis complex in various clinical samples. J Clin Microbiol 2011;49:1700-1.
23. Davis JL, Huang L, Worodria W, et al. Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study. PLoS One 2011;6:e16321.
24. Chou PC, Wang CH, Huang CD, et al. Nucleic acid amplification test and bronchoscopy improve the diagnostic accuracy of smear-negative tuberculosis. Int J Tuberc Lung Dis 2012;16:1674-79.
25. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011;184:132-40.
26. Theron G, Pinto L, Peter J, et al. The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients. Clin Infect Dis 2012;54:384-88.
27. Perrin F, Woodward N, Phillips P, et al. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010;14:1596-602.
28. Hesseling A, Walzl G, Enarson D, et al. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis 2010;14:560-70.
29. Visser ME, Stead MC, Walzl G, et al. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PLoS One 2012;7:e29588.
30. Bark CM, Thiel BA, Johnson JL. Pretreatment time to detection of mycobacterium tuberculosis in liquid culture is associated with relapse after therapy. J Clin Microbiol 2012;50:538-38.
31. Fennelly KP. An eXpert AFB smear? Clin Infect Dis 2012;54:389-91.
32. Peter JG, Theron G, Muchinga TE, et al. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One 2012;7:e39966.
33. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. The Lancet 2011;377:1495-505.
34. Yoon C, Cattamanchi A, Davis JL, et al. Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLoS One 2012;7:e48599.
35. Moure R, Munoz L, Torres M, et al. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 2011;49:1137-39.